🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the tolerability and safety of combination of ONO-4578 and ONO-...
Status
Active Not Recruiting
Location
National Cancer Center Hospital East
Start Date
2021-01-13
Trial ID
NCT06547385
Treatments Being Tested
This is a two-group, parallel, randomized, standard-control phase II study ...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-09-01
Trial ID
NCT05077839
Treatments Being Tested
The purpose of this study is to determine if RAD001 (everolimus) helps impr...
Status
Completed
Location
Ingalls Cancer Research Center
Start Date
2009-07
Trial ID
NCT00849550
Treatments Being Tested
The aim of this work is to assess the antitumor effect of Pentoxiphylline i...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06115174
Treatments Being Tested
This study will be a prospective one conducted within a time frame between ...
Status
Completed
Location
Baghdad Medical city
Start Date
2022-09-01
Trial ID
NCT06843954
Treatments Being Tested
To improve the survival in patients with microsatellite stable metastatic c...
Status
Recruiting
Location
Fudan University
Start Date
2024-03-01
Trial ID
NCT06841159
Treatments Being Tested
The primary aim of this study is to investigate whether the addition of the...
Status
Terminated
Location
Universitair Medisch Centrum Utrecht
Start Date
2006-12
Trial ID
NCT00394992
Treatments Being Tested
This is an open-label, multicenter Phase 2 clinical study designed to evalu...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2026-04-25
Trial ID
NCT07503756
Treatments Being Tested
This is a multicenter, global, Phase 2, open-label, 2-part, first-line stud...
Status
Completed
Location
USC/Norris Comprehensive Cancer Center
Start Date
2019-08-29
Trial ID
NCT03929666
This phase II, open-label, dose-escalation study aims to (1) assess the saf...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-09
Trial ID
NCT06858969
Treatments Being Tested